|
|
| Product Name: | R-1530 | | Synonyms: | R 1530;R1530;R-1530;5-(2-Chlorophenyl)-7-fluoro-1,2-dihydro-8-methoxy-3-methylpyrazolo[3,4-b][1,4]benzodiazepine;R 1530, >=98%;R-1521;CS-1111;R 1530; R-1530 | | CAS: | 882531-87-5 | | MF: | C18H14ClFN4O | | MW: | 356.78 | | EINECS: | | | Product Categories: | | | Mol File: | 882531-87-5.mol |  |
| | R-1530 Chemical Properties |
| Boiling point | 550.9±50.0 °C(Predicted) | | density | 1.46±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO: soluble20mg/mL, clear | | form | powder | | pka | 17.23±0.40(Predicted) | | color | white to yellow to light brown |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26 | | WGK Germany | 3 |
| | R-1530 Usage And Synthesis |
| Uses | R 1530 is a multi-kinase inhibitor. It exhibits inhibitory activity against Chk2, KDR, FGFR, Aurora A kinase and Cdk2. It also binds VEGFR-2, FGFR1 and PDGFRβ. It displays antiproliferative activity in vitro and inhibits mitosis and angiogenesis. |
| | R-1530 Preparation Products And Raw materials |
|